Navigation Links
InterMune Reports First Quarter 2011 Financial Results and Business Highlights
Date:4/28/2011

mune.com.Actimmune® and Esbriet® are registered trademarks of InterMune, Inc.  

Financial tables follow:InterMune, Inc.PRELIMINARY CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(unaudited, in thousands, except per share amounts)Three Months EndedMarch 3120112010Revenue, net  Actimmune

$

5,052$

5,264  Collaboration revenue1,300818   Total revenue, net6,3526,082Costs and expenses:  Cost of goods sold2,2862,643  Research and development16,83820,477  General and administrative17,57615,131Total costs and expenses36,70038,251Loss from operations(30,348)(32,169)Interest income138177Interest expense(1,787)(2,101)Other income (expense)(106)15Loss from operations before income taxes(32,103)(34,078)Income tax expense (benefit)--Net loss

$

(32,103)$

(34,078)Basic and diluted loss per share:Net loss per share

$

(0.57)$

(0.66)Shares used in computing basic and diluted net loss per share56,37751,930InterMune, Inc.PRELIMINARY CONDENSED CONSOLIDATED BALANCE SHEETS(unaudited, in thousands)March 31December 31,20112010Cash, cash equivalents and available-for-sale securities

$

254,282$

295,073Acquired product rights20,000-Other assets11,35110,074  Total assets

$

285,633$

305,147Total other liabilities

$

24,692$

26,547Convertible senior notes85,000129,300Stockholders’ equity (deficit)175,941149,300  Total liabilities and stockholders’ equity (deficit)

$

285,633$

305,147
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. InterMune to Present at Canaccord Adams Conference
2. InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche
3. InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting
4. InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF
5. InterMune to Release Third Quarter 2008 Financial Results on November 6
6. InterMune Reports Third Quarter 2008 Financial Results and Business Highlights
7. InterMune to Present at Deutsche Bank Biotech Boston Confab
8. InterMune to Present at J.P. Morgan Healthcare Conference
9. InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF
10. InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock
11. InterMune Announces Issuance of U.S. Patent for ITMN-191
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013   Flexion Therapeutics , ... W. Driscoll to its management team as ... years of financial management experience with biotechnology and medical ... Driscoll was chief financial officer for Novavax (NASDAQ: ... secured more than $250 million through a combination of ...
(Date:5/20/2013)... On 25-28 July, 2013, UPCP 2013 ... - the beautiful city of lights. , According to ... revolutionizing the medical world. Understanding and integrating genetic and ... of this transformation. Much of the present medical practice ... studies of large cohorts that do not take into ...
(Date:5/19/2013)... 2013 The JM Internet Group (web: ... has proudly announced that the company's YouTube channel on ... 175,000 views on YouTube. The company uses YouTube as ... tips and training for small businesses with much success. ... YouTube tips helpful for their SEO strategies", explained Jason ...
(Date:5/17/2013)... news release is available in German . ... too well: with the naked eye, you can see which ... in the blur of branches through the telephoto lens for ... for researchers who are looking to study proteins, the active ... ETH Zurich,s Institute for Molecular Systems Biology, and her colleagues ...
Breaking Biology Technology:Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris 2YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3
... the Wisconsin Alumni Research Foundation's European stem ... , ,The foundation's stem cell patent is controversial enough ... overly broad and is suppressing scientific research. While that ... than 300 academic licenses it has issued for stem ...
... is entering a new phase. Both are headed to a jumpsuit ... years but the ex-heads of Enron - Ken Lay and Jeff ... thoroughly non-gullible jury of their fellow Houstonians. The duo will soon ... their crimes. , , When Creative Becomes Criminal ...
... always taken for granted was the quality of sound on ... emphasized that "you can hear a pin drop" as they ... ,The old Bell system also had very stringent requirements for ... digital lines with digital repeaters (amplifiers) that actually regenerated the ...
Cached Biology Technology:WARF stem cell patent faces long and winding road 2WARF stem cell patent faces long and winding road 3WARF stem cell patent faces long and winding road 4WARF stem cell patent faces long and winding road 5Are there more Enrons out there? 2Are there more Enrons out there? 3Are there more Enrons out there? 4Is traditional voice quality an oxymoron with today's cellular, VoIP? 2Is traditional voice quality an oxymoron with today's cellular, VoIP? 3
(Date:5/17/2013)... A new Dartmouth College study finds human-caused climate ... of tropical lizards, contradicting a host of recent ... rapidly warming planet. , The findings, which appear ... offer new hope for survival of a creature ... Most predictions that tropical cold-blooded animals, especially forest ...
(Date:5/16/2013)... MARC (Maximizing Access to Research Careers) Program has ... Society (ENDO) 95th Annual Meeting in San Francisco, ... meant to promote the entry of students, postdoctorates ... of the basic science community and to encourage ... 2013 Annual Meeting. , Awards are given to ...
(Date:5/16/2013)... University scientists have shown a gene involved in neurodegenerative ... function of the circadian clock. , In a ... the gene, called Ataxin-2, keeps the clock responsible for ... gene, the rhythm of the fruit fly,s sleep-wake cycle ... difficult for the fly. , The discovery is ...
Breaking Biology News(10 mins):Climate change may have little impact on tropical lizards 2Gene involved in neurodegeneration keeps clock running 2
... - the idea of using genetic instructions rather than drugs ... but is not yet a viable therapeutic method. One ... place at the right time. , Engineers at the University ... problem. David M. Lynn and his colleagues have created ...
... hit all his developmental landmarks but after his first birthday he ... infection. He stopped eating and was no longer happy and playful. ... at us anymore; he was in his own little world. At ... and was smearing (feces) on the walls. My baby had been ...
... the urgent need for alternative energy, Florida Tech ... a $430,000 contract from Aurora Biofuels for large-scale ... so far is in small-scale cultivation. , Lin ... Vero Beach Marine Laboratory. His work is to ...
Cached Biology News:Ultrathin films deliver DNA as possible gene therapy tool 2Ultrathin films deliver DNA as possible gene therapy tool 3Army research mission focused on autism 2Army research mission focused on autism 3Army research mission focused on autism 4
Human SOST Affinity Purified Polyclonal Ab...
(3-[125I]iodotyrosyl26)Galanin, porcine, 370 kBq, 10 uCi. Category: IODINE LIGANDS....
(3-[125I]iodotyrosyl26)Galanin (porcine), 925 kBq, 25 uCi. Category: IODINE LIGANDS....
Human Legumain Affinity Purified Polyclonal Ab...
Biology Products: